Combination of alcohol and glucose consumption as a risk to induce reactive hypoglycemia. 2021

Chiho Oba-Yamamoto, and Jun Takeuchi, and Akinobu Nakamura, and Ryoko Takikawa, and Ayano Ozaki, and Hiroshi Nomoto, and Hiraku Kameda, and Kyu Yong Cho, and Tatsuya Atsumi, and Hideaki Miyoshi
Sapporo Diabetes and Thyroid Clinic, Sapporo, Japan.

OBJECTIVE Alcohol consumption has been reported to cause hypoglycemia. However, the mechanism involved has not been unequivocally established. This study comprised healthy volunteers. We carried out a prospective trial to compare the effects of glucose and alcohol consumption, alone or in combination, on glucose and lipid metabolism. METHODS A 75-g oral glucose tolerance test (OGTT), a combined 75-g glucose plus 20-g alcohol tolerance test (OGATT) and a 20-g alcohol tolerance test (OATT) were carried out in the participants. Plasma glucose, insulin, triglyceride and ethanol concentrations during each test were compared. RESULTS We studied 10 participants. Their plasma glucose concentrations 15 and 30 min after the intake of 75 g of glucose were significantly higher during the OGATT than the OGTT. Hypoglycemia occurred in five participants after the OGATT, which was significantly more frequently than after the OGTT (P = 0.046). Hypoglycemia did not occur after the OATT, and the ethanol concentration was significantly lower after the OGATT than the OATT. The changes in triglyceride concentration from 30 min after the consumption of 75 g of glucose were significantly greater during the OGATT than the OGTT. The plasma insulin concentrations peaked after 60 min during both the OGTT and OGATT, and were significantly higher during the OGATT (P = 0.047). There were no differences between the two interventions in the Matsuda or disposition indexes. CONCLUSIONS Hypoglycemia occurred more frequently after the simultaneous consumption of alcohol plus glucose than after the consumption of glucose alone, suggesting that alcohol in the combination of glucose induces reactive hypoglycemia.

UI MeSH Term Description Entries
D007003 Hypoglycemia A syndrome of abnormally low BLOOD GLUCOSE level. Clinical hypoglycemia has diverse etiologies. Severe hypoglycemia eventually lead to glucose deprivation of the CENTRAL NERVOUS SYSTEM resulting in HUNGER; SWEATING; PARESTHESIA; impaired mental function; SEIZURES; COMA; and even DEATH. Fasting Hypoglycemia,Postabsorptive Hypoglycemia,Postprandial Hypoglycemia,Reactive Hypoglycemia,Hypoglycemia, Fasting,Hypoglycemia, Postabsorptive,Hypoglycemia, Postprandial,Hypoglycemia, Reactive
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002492 Central Nervous System Depressants A very loosely defined group of drugs that tend to reduce the activity of the central nervous system. The major groups included here are ethyl alcohol, anesthetics, hypnotics and sedatives, narcotics, and tranquilizing agents (antipsychotics and antianxiety agents). CNS Depressants,Depressants, CNS
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

Chiho Oba-Yamamoto, and Jun Takeuchi, and Akinobu Nakamura, and Ryoko Takikawa, and Ayano Ozaki, and Hiroshi Nomoto, and Hiraku Kameda, and Kyu Yong Cho, and Tatsuya Atsumi, and Hideaki Miyoshi
March 1974, Deutsche medizinische Wochenschrift (1946),
Chiho Oba-Yamamoto, and Jun Takeuchi, and Akinobu Nakamura, and Ryoko Takikawa, and Ayano Ozaki, and Hiroshi Nomoto, and Hiraku Kameda, and Kyu Yong Cho, and Tatsuya Atsumi, and Hideaki Miyoshi
November 1976, Nederlands tijdschrift voor geneeskunde,
Chiho Oba-Yamamoto, and Jun Takeuchi, and Akinobu Nakamura, and Ryoko Takikawa, and Ayano Ozaki, and Hiroshi Nomoto, and Hiraku Kameda, and Kyu Yong Cho, and Tatsuya Atsumi, and Hideaki Miyoshi
November 1980, Virginia medical,
Chiho Oba-Yamamoto, and Jun Takeuchi, and Akinobu Nakamura, and Ryoko Takikawa, and Ayano Ozaki, and Hiroshi Nomoto, and Hiraku Kameda, and Kyu Yong Cho, and Tatsuya Atsumi, and Hideaki Miyoshi
December 1971, Physiology & behavior,
Chiho Oba-Yamamoto, and Jun Takeuchi, and Akinobu Nakamura, and Ryoko Takikawa, and Ayano Ozaki, and Hiroshi Nomoto, and Hiraku Kameda, and Kyu Yong Cho, and Tatsuya Atsumi, and Hideaki Miyoshi
December 2023, American journal of preventive medicine,
Chiho Oba-Yamamoto, and Jun Takeuchi, and Akinobu Nakamura, and Ryoko Takikawa, and Ayano Ozaki, and Hiroshi Nomoto, and Hiraku Kameda, and Kyu Yong Cho, and Tatsuya Atsumi, and Hideaki Miyoshi
January 2019, BMJ (Clinical research ed.),
Chiho Oba-Yamamoto, and Jun Takeuchi, and Akinobu Nakamura, and Ryoko Takikawa, and Ayano Ozaki, and Hiroshi Nomoto, and Hiraku Kameda, and Kyu Yong Cho, and Tatsuya Atsumi, and Hideaki Miyoshi
March 1996, Clinica chimica acta; international journal of clinical chemistry,
Chiho Oba-Yamamoto, and Jun Takeuchi, and Akinobu Nakamura, and Ryoko Takikawa, and Ayano Ozaki, and Hiroshi Nomoto, and Hiraku Kameda, and Kyu Yong Cho, and Tatsuya Atsumi, and Hideaki Miyoshi
May 1990, Physiology & behavior,
Chiho Oba-Yamamoto, and Jun Takeuchi, and Akinobu Nakamura, and Ryoko Takikawa, and Ayano Ozaki, and Hiroshi Nomoto, and Hiraku Kameda, and Kyu Yong Cho, and Tatsuya Atsumi, and Hideaki Miyoshi
February 1990, Metabolism: clinical and experimental,
Chiho Oba-Yamamoto, and Jun Takeuchi, and Akinobu Nakamura, and Ryoko Takikawa, and Ayano Ozaki, and Hiroshi Nomoto, and Hiraku Kameda, and Kyu Yong Cho, and Tatsuya Atsumi, and Hideaki Miyoshi
September 2005, Diabetes research and clinical practice,
Copied contents to your clipboard!